A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol

NCT02227784 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

366

Enrollment

INDUSTRY

Sponsor class

Stopped Study termination due to program termination.

Conditions

Hyperlipidemia

Interventions

DRUG: Evacetrapib
DRUG: Atorvastatin
DRUG: Ezetimibe
DRUG: Placebo

Sponsor

Eli Lilly and Company